Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia

Kenneth C H Fearon, Matthew D Barber, Alastair G Moses, Sam H Ahmedzai, Gillian S Taylor, Michael J Tisdale, Gordon D Murray

Research output: Contribution to journalArticlepeer-review

Abstract

Eicosapentaenoic acid (EPA) has been proposed to have specific anticachectic effects. This trial compared EPA diethyl ester with placebo in cachectic cancer patients for effects on weight and lean body mass.
Original languageEnglish
Pages (from-to)3401-7
Number of pages7
JournalJournal of Clinical Oncology
Volume24
Issue number21
DOIs
Publication statusPublished - 2006

Keywords

  • Adult
  • Aged
  • Analysis of Variance
  • Body Composition
  • Body Mass Index
  • Body Weight
  • Cachexia
  • Double-Blind Method
  • Eicosapentaenoic Acid
  • Female
  • Humans
  • Karnofsky Performance Status
  • Male
  • Middle Aged
  • Neoplasms
  • Quality of Life
  • Questionnaires
  • Survival Analysis

Fingerprint

Dive into the research topics of 'Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia'. Together they form a unique fingerprint.

Cite this